Morphic to Participate in Jefferies Global Healthcare Conference
May 31 2024 - 7:00AM
Morphic Therapeutic (Nasdaq: MORF), a biotechnology company
developing a new generation of oral integrin therapies for the
treatment of serious chronic diseases, today announced that members
of its management team will take part in a fireside chat at the
2024 Jefferies Global Healthcare Conference on Wednesday, June 5th,
at 10:30 AM ET.
A live webcast of the panel discussion and
fireside chat at the Jefferies Global Healthcare Conference will be
available on the Investor section of Morphic’s website
at www.morphictx.com. An archived replay will be available on
the company’s website following the conference.
About Morphic
TherapeuticMorphic Therapeutic is a biopharmaceutical
company developing a portfolio of oral integrin therapies for the
treatment of serious chronic diseases, including autoimmune,
cardiovascular, and metabolic diseases, fibrosis, and cancer.
Morphic is also advancing its pipeline and discovery activities in
collaboration with Schrödinger using its proprietary MInT
technology platform which leverages the Company’s unique
understanding of integrin structure and biology. For more
information, visit www.morphictx.com.
ContactsMorphic TherapeuticChris
Erdmanchris.erdman@morphictx.com617.686.1718
Morphic (NASDAQ:MORF)
Historical Stock Chart
From Aug 2024 to Sep 2024
Morphic (NASDAQ:MORF)
Historical Stock Chart
From Sep 2023 to Sep 2024